POLATUZUMAB VEDOTIN WITH BENDAMUSTINE AND RITUXIMAB FOR RELAPSED/REFRACTORY HIGH‐GRADE B‐CELL LYMPHOMA: THE UK EXPERIENCE. (17th June 2021)

• Record Type: Journal Article
• Authors: Northend, M.; Wilson, W.; Osborne, W.; Fox, C. P.; Davies, A. J; El‐Sharkawi, D.; Phillips, E. H.; Sim, H. W.; Sadullah, S.; Shah, N.; Peng, Y. Y.; Qureshi, I.; Addada, J.; Mora, R. F.; Phillips, N.; Kuhnl, A.; Davies, E.; Wrench, D.; McKay, P.; Karpha, I.; Cowley, A.; Karim, R.; Challenor, S.; Singh, V.; Burton, C.; Auer, R.; Williams, C.; Broom, A.; Roddie, C.; Townsend, W.
• Is Part Of: Hematological oncology. Volume 39(2021)Supplement 2
• Page Start: n/a
• Page End: n/a
• Publication Date: 2021-06-17
• Subjects: Hematological oncology -- Periodicals; Hematology; Medical Oncology; 616.99418005
• DOI: 10.1002/hon.86_2880
• Languages: English
• ISSNs: 0278-0232